#glp-1-obesity-and-diabetes-drugs

[ follow ]
Business
from24/7 Wall St.
2 days ago

Is Eli Lilly Going To $1,100?

Eli Lilly delivered strong Q1 2026 results driven by Mounjaro and Zepbound, supporting a $1,164.85 price target and bullish outlook despite pricing risks.
[ Load more ]